Nature - the world's best science and medicine on your desktop http://www.nature.com/news/ Nature Publishing Group en Nature Publishing Group News at Nature © 2009 Nature Publishing Group permissions@nature.com 1744-7933 http://feeds.nature.com/~r/news/rss/news_s1/~3/ijMfgfzVGLk/news.2011.621.html Human serum albumin from transgenic rice could ease shortages of donated blood.<img src="http://feeds.feedburner.com/~r/news/rss/news_s1/~4/ijMfgfzVGLk" height="1" width="1"/> Rice seed yields blood protein 10.1038/news.2011.621 Nature 2011-10-31T19:00:00-0400 News at Nature Mon Oct 31 19:00:00 EDT 2011 http://www.nature.com/news/2011/111031/full/news.2011.621.html?s=news_rss http://www.nature.com/news/2011/111028/full/news.2011.618.html?s=news_rss Partner institute in Buenos Aires will focus on neuroscience and drug development. Max Planck Society opens South American outpost 10.1038/news.2011.618 Nature 2011-10-28T10:05:27-0400 News at Nature Fri Oct 28 10:05:27 EDT 2011 http://www.nature.com/news/2011/111025/full/478440a.html?s=news_rss Non-invasive procedure could make prenatal testing easier, but it comes with ethical problems. Fetal gene screening comes to market 10.1038/478440a Nature 2011-10-25T15:13:44-0400 News at Nature Tue Oct 25 15:13:44 EDT 2011 http://www.nature.com/news/2011/111024/full/478441a.html?s=news_rss Researchers can work without fear of action over patent infringement. European ban on stem-cell patents has a silver lining 10.1038/478441a Nature 2011-10-24T18:30:00-0400 News at Nature Mon Oct 24 18:30:00 EDT 2011 http://www.nature.com/news/2011/111024/full/news.2011.609.html?s=news_rss Promising phase III trial paves the way for alemtuzumab approval. Antibody offers hope for multiple sclerosis treatment 10.1038/news.2011.609 Nature 2011-10-24T15:13:02-0400 News at Nature Mon Oct 24 15:13:02 EDT 2011 http://www.nature.com/news/2011/111018/full/news.2011.597.html?s=news_rss Final decision could stifle investment in developing therapies. European court bans patents based on embryonic stem cells 10.1038/news.2011.597 Nature 2011-10-18T16:33:47-0400 News at Nature Tue Oct 18 16:33:47 EDT 2011 http://www.nature.com/news/2011/111018/full/478295a.html?s=news_rss As outbreak enters its second year, relief bodies move to roll out vaccine for the first time. No quick fix for Haiti cholera 10.1038/478295a Nature 2011-10-18T16:08:32-0400 News at Nature Tue Oct 18 16:08:32 EDT 2011 http://www.nature.com/news/2011/111005/full/news.2011.578.html?s=news_rss Researchers begin to identify past problems with cloning technique. Cloned human embryo makes working stem cells 10.1038/news.2011.578 Nature 2011-10-05T17:00:00-0400 News at Nature Wed Oct 05 17:00:00 EDT 2011 http://www.nature.com/news/2011/110930/full/news.2011.568.html?s=news_rss Deal between Amyris and Michelin highlights industry's hunt for a profitable niche. Renewable rubber hits the road 10.1038/news.2011.568 Nature 2011-09-30T18:35:37-0400 News at Nature Fri Sep 30 18:35:37 EDT 2011 http://www.nature.com/news/2011/110928/full/news.2011.562.html?s=news_rss With hundreds of nanoproducts currently being tested in humans, recommendations aim to safeguard trial participants. Draft guidelines for nanomedicine unveiled 10.1038/news.2011.562 Nature 2011-09-28T17:39:39-0400 News at Nature Wed Sep 28 17:39:39 EDT 2011 http://www.nature.com/news/2011/110926/full/news.2011.557.html?s=news_rss Undercover E. coli act as updated invisible ink. Bacteria encode secret messages 10.1038/news.2011.557 Nature 2011-09-26T19:00:00-0400 News at Nature Mon Sep 26 19:00:00 EDT 2011 http://www.nature.com/news/2011/110920/full/477377a.html?s=news_rss Enthusiasm for unapproved treatments worries regulators. Texas prepares to fight for stem cells 10.1038/477377a Nature 2011-09-20T15:44:42-0400 News at Nature Tue Sep 20 15:44:42 EDT 2011 http://www.nature.com/news/2011/110913/full/477259a.html?s=news_rss Academia and industry join forces to carve out ten-year plan. US plant scientists seek united front 10.1038/477259a Nature 2011-09-13T16:23:38-0400 News at Nature Tue Sep 13 16:23:38 EDT 2011 http://www.nature.com/news/2011/110907/full/477150a.html?s=news_rss Since the anthrax attacks in 2001, some $60 billion has been spent on biodefence in the United States. But the money has not bought quite what was hoped. Biodefence since 9/11: The price of protection 10.1038/477150a Nature 2011-09-07T17:00:00-0400 News at Nature Wed Sep 07 17:00:00 EDT 2011 http://www.nature.com/news/2011/110905/full/news.2011.519.html?s=news_rss Mechanism by which microbes scrub radioactive contamination revealed. Electrified bacterial filaments zap uranium 10.1038/news.2011.519 Nature 2011-09-05T19:00:00-0400 News at Nature Mon Sep 05 19:00:00 EDT 2011 http://www.nature.com/includes/rj_globnavimages/news_logo.gif http://www.nature.com/news/